» Articles » PMID: 37415863

A Model-informed Method to Retrieve Intrinsic from Apparent Cooperativity and Project Cellular Target Occupancy for Ternary Complex-forming Compounds

Overview
Journal RSC Chem Biol
Specialty Biology
Date 2023 Jul 7
PMID 37415863
Authors
Affiliations
Soon will be listed here.
Abstract

There is an increasing interest to develop therapeutics that modulate challenging or undruggable target proteins a mechanism that involves ternary complexes. In general, such compounds can be characterized by their direct affinities to a chaperone and a target protein and by their degree of cooperativity in the formation of the ternary complex. As a trend, smaller compounds have a greater dependency on intrinsic cooperativity to their thermodynamic stability relative to direct target (or chaperone) binding. This highlights the need to consider intrinsic cooperativity of ternary complex-forming compounds early in lead optimization, especially as they provide more control over target selectivity (especially for isoforms) and more insight into the relationship between target occupancy and target response estimation of ternary complex concentrations. This motivates the need to quantify the natural constant of intrinsic cooperativity () which is generally defined as the gain (or loss) in affinity of a compound to its target in pre-bound unbound state. Intrinsic cooperativities can be retrieved a mathematical binding model from EC shifts of binary binding curves of the ternary complex-forming compound with either a target or chaperone relative to the same experiment but in the presence of the counter protein. In this manuscript, we present a mathematical modeling methodology that estimates the intrinsic cooperativity value from experimentally observed apparent cooperativities. This method requires only the two binary binding affinities and the protein concentrations of target and chaperone and is therefore suitable for use in early discovery therapeutic programs. This approach is then extended from biochemical assays to cellular assays (, from a closed system to an open system) by accounting for differences in total ligand free ligand concentrations in the calculations of ternary complex concentrations. Finally, this model is used to translate biochemical potency of ternary complex-forming compounds into expected cellular target occupancy, which could ultimately serve as a way for validation or de-validation of hypothesized biological mechanisms of action.

Citing Articles

Identification and characterization of ternary complexes consisting of FKBP12, MAPRE1 and macrocyclic molecular glues.

Salcius M, Tutter A, Fouche M, Koc H, King D, Dhembi A RSC Chem Biol. 2025; .

PMID: 40059881 PMC: 11883961. DOI: 10.1039/d4cb00279b.

References
1.
Zang R, Barth A, Wong H, Marik J, Shen J, Lade J . Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation. J Med Chem. 2022; 65(13):8713-8734. DOI: 10.1021/acs.jmedchem.2c00502. View

2.
Sijbesma E, Hallenbeck K, Andrei S, Rust R, Adriaans J, Brunsveld L . Exploration of a 14-3-3 PPI Pocket by Covalent Fragments as Stabilizers. ACS Med Chem Lett. 2021; 12(6):976-982. PMC: 8201753. DOI: 10.1021/acsmedchemlett.1c00088. View

3.
Hu Z, Crews C . Recent Developments in PROTAC-Mediated Protein Degradation: From Bench to Clinic. Chembiochem. 2021; 23(2):e202100270. PMC: 9395155. DOI: 10.1002/cbic.202100270. View

4.
de Vink P, Andrei S, Higuchi Y, Ottmann C, Milroy L, Brunsveld L . Cooperativity basis for small-molecule stabilization of protein-protein interactions. Chem Sci. 2019; 10(10):2869-2874. PMC: 6429609. DOI: 10.1039/c8sc05242e. View

5.
Hu B, Zhou Y, Sun D, Yang Y, Liu Y, Li X . PROTACs: New method to degrade transcription regulating proteins. Eur J Med Chem. 2020; 207:112698. DOI: 10.1016/j.ejmech.2020.112698. View